摘要
糖尿病足是糖尿病最严重的慢性并发症之一,具有较高的致残率和致死率,其发病机制十分复杂,与外周神经病变和下肢动脉缺血有关,也与外伤、感染、营养不良和肾功能不全等局部和全身情况有关。针对病因的去除或是改善是糖尿病足创面治疗的关键部分,但是采取方法促进糖尿病足创面的愈合以改善糖尿病患者的预后也是当前医学界关注的焦点。以自体植皮为代表的人体自体成分在创面治疗中发挥重要作用。近年来,人体自体成分在糖尿病足创面的应用及研究不断涌现,在促进糖尿病足创面愈合等方面取得了良好的疗效。Diabetic foot is one of the most serious chronic complications of diabetes, with high disability and mortality rates. Its pathogenesis is very complex and is related to peripheral neuropathy and lower extremity arterial ischemia, as well as local and systemic conditions such as trauma, infection, malnutrition and renal insufficiency. Removing or improving the cause is the key part of diabetic foot wound treatment, but taking methods to promote the healing of diabetic foot wounds to improve the prognosis of diabetic patients is also the focus of current medical attention. Human autologous components represented by autologous skin grafts play an important role in wound treatment. In recent years, the application and research of human autologous components in diabetic foot wounds have continued to emerge, and have achieved good therapeutic effects in promoting the healing of diabetic foot wounds.
出处
《临床医学进展》
2024年第9期229-235,共7页
Advances in Clinical Medicine
